Literature DB >> 9103298

Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone.

Y Grosse1, L Chekir-Ghedira, A Huc, S Obrecht-Pflumio, G Dirheimer, H Bacha, A Pfohl-Leszkowicz.   

Abstract

Ochratoxin A (OTA), and zearalenone (ZEN), two mycotoxins, have been implicated in numerous mycotoxicoses in farm animals and are genotoxic. Several adducts were detected in mouse and rat kidney after a single administration of OTA and in mice organs after zearalenone treatment which induces hepatocellular adenomas. The effects of some vitamins such as retinol (A), ascorbic acid (C) and alpha-tocopherol (E), which are known to act as superoxide anion scavengers, were tested on OTA genotoxicity. Pretreatment of mice by vitamin E decreased DNA adducts by 80% in kidney. Vitamin A decreased DNA adduct levels by 70% and Vitamin C by 90% in kidney. In the same way, pretreatment of female mice with alpha-tocopherol before administration of zearalenone inhibited significantly DNA adduct formation in liver and in kidney. The total DNA adduct level after E treatment was decreased by 45% and 58% in liver and kidney respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103298     DOI: 10.1016/s0304-3835(97)04669-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Role of zearalenone lactonase in protection of Gliocladium roseum from fungitoxic effects of the mycotoxin zearalenone.

Authors:  Jan Utermark; Petr Karlovsky
Journal:  Appl Environ Microbiol       Date:  2006-11-17       Impact factor: 4.792

2.  Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy.

Authors:  Romina di Giuseppe; Terenzio Bertuzzi; Filippo Rossi; Silvia Rastelli; Annalisa Mulazzi; Jessica Capraro; Amalia de Curtis; Licia Iacoviello; Amedeo Pietri
Journal:  Eur J Nutr       Date:  2011-10-29       Impact factor: 5.614

Review 3.  Research Progress of Safety of Zearalenone: A Review.

Authors:  Xiao Han; Bingxin Huangfu; Tongxiao Xu; Wentao Xu; Charles Asakiya; Kunlun Huang; Xiaoyun He
Journal:  Toxins (Basel)       Date:  2022-06-02       Impact factor: 5.075

4.  Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress.

Authors:  Nieves Palma; Serena Cinelli; Orazio Sapora; Samuel H Wilson; Eugenia Dogliotti
Journal:  Chem Res Toxicol       Date:  2007-06-14       Impact factor: 3.739

Review 5.  Ochratoxins in feed, a risk for animal and human health: control strategies.

Authors:  Muzaffer Denli; Jose F Perez
Journal:  Toxins (Basel)       Date:  2010-05-13       Impact factor: 4.546

6.  Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a.

Authors:  M Marin-Kuan; V Ehrlich; T Delatour; C Cavin; B Schilter
Journal:  J Toxicol       Date:  2011-06-22

7.  Alpha-tocopherol counteracts the cytotoxicity induced by ochratoxin a in primary porcine fibroblasts.

Authors:  Eleonora Fusi; Raffaella Rebucci; Chiara Pecorini; Anna Campagnoli; Luciano Pinotti; Francesca Saccone; Federica Cheli; Stig Purup; Kristen Sejrsen; Antonella Baldi
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

Review 8.  Chemical, physical and biological approaches to prevent ochratoxin induced toxicoses in humans and animals.

Authors:  János Varga; Sándor Kocsubé; Zsanett Péteri; Csaba Vágvölgyi; Beáta Tóth
Journal:  Toxins (Basel)       Date:  2010-07-01       Impact factor: 4.546

Review 9.  A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis.

Authors:  Janette H Hope; Bradley E Hope
Journal:  J Environ Public Health       Date:  2011-12-29

10.  Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice.

Authors:  Aly M Ezz El-Arab; Shenouda M Girgis; Eman M Hegazy; Azzat B Abd El-Khalek
Journal:  BMC Complement Altern Med       Date:  2006-03-14       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.